iExosomes in Treating Participants With Metastatic Pancreas Cancer With KrasG12D Mutation
Abroad (travel likely)RecruitingPHASE1, PHASE2
Conditions
KRAS NP_004976.2:p.G12D · Metastatic Pancreatic Adenocarcinoma · Pancreatic Ductal Adenocarcinoma · Stage IV Pancreatic Cancer AJCC v8
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
M D Anderson Cancer Center, Houston, Texas, United States
Contact: Principal Investigator (Brandon Smaglo)
Study leads
Brandon Smaglo, MD
Principal Investigator
M.D. Anderson Cancer Center